Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.30
+0.33 (5.53%)
At close: Dec 10, 2025, 4:00 PM EST
6.42
+0.12 (1.90%)
After-hours: Dec 10, 2025, 6:31 PM EST
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $317.99 million as of December 10, 2025. Its market cap has increased by 153.45% in one year.
Market Cap
317.99M
Enterprise Value
258.95M
1-Year Change
153.45%
Ranking
Category
Stock Price
$6.30
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $317.99M, an increase of 416.07%. That is a compound annual growth rate of 41.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 303.18M | 171.53% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
| Mar 9, 2021 | 61.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |